Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
1996-12-6
pubmed:abstractText
The importance of endothelin-1 in chronic heart failure (CHF) is unclear. We therefore investigated the effects of endothelin-converting enzyme (ECE) inhibition and endothelin ETA receptor blockade in CHF patients treated with ACE inhibitors. We also compared the function of ETA and ETB receptors in healthy subjects and patients with CHF.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin-Converting Enzyme..., http://linkedlifedata.com/resource/pubmed/chemical/Aspartic Acid Endopeptidases, http://linkedlifedata.com/resource/pubmed/chemical/Endothelin-1, http://linkedlifedata.com/resource/pubmed/chemical/Glycopeptides, http://linkedlifedata.com/resource/pubmed/chemical/Metalloendopeptidases, http://linkedlifedata.com/resource/pubmed/chemical/Neprilysin, http://linkedlifedata.com/resource/pubmed/chemical/Peptides, Cyclic, http://linkedlifedata.com/resource/pubmed/chemical/Protease Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Endothelin A, http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Endothelin B, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Endothelin, http://linkedlifedata.com/resource/pubmed/chemical/Vasoconstrictor Agents, http://linkedlifedata.com/resource/pubmed/chemical/Viper Venoms, http://linkedlifedata.com/resource/pubmed/chemical/cyclo(Trp-Asp-Pro-Val-Leu), http://linkedlifedata.com/resource/pubmed/chemical/endothelin-converting enzyme, http://linkedlifedata.com/resource/pubmed/chemical/phosphoramidon, http://linkedlifedata.com/resource/pubmed/chemical/sarafotoxins s6
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0009-7322
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
94
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2131-7
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:8901663-Aged, pubmed-meshheading:8901663-Analysis of Variance, pubmed-meshheading:8901663-Angiotensin-Converting Enzyme Inhibitors, pubmed-meshheading:8901663-Aspartic Acid Endopeptidases, pubmed-meshheading:8901663-Brachial Artery, pubmed-meshheading:8901663-Chronic Disease, pubmed-meshheading:8901663-Endothelin-1, pubmed-meshheading:8901663-Female, pubmed-meshheading:8901663-Glycopeptides, pubmed-meshheading:8901663-Heart Failure, pubmed-meshheading:8901663-Humans, pubmed-meshheading:8901663-Male, pubmed-meshheading:8901663-Metalloendopeptidases, pubmed-meshheading:8901663-Middle Aged, pubmed-meshheading:8901663-Neprilysin, pubmed-meshheading:8901663-Peptides, Cyclic, pubmed-meshheading:8901663-Protease Inhibitors, pubmed-meshheading:8901663-Receptor, Endothelin A, pubmed-meshheading:8901663-Receptor, Endothelin B, pubmed-meshheading:8901663-Receptors, Endothelin, pubmed-meshheading:8901663-Regional Blood Flow, pubmed-meshheading:8901663-Vasoconstriction, pubmed-meshheading:8901663-Vasoconstrictor Agents, pubmed-meshheading:8901663-Vasodilation, pubmed-meshheading:8901663-Viper Venoms
pubmed:year
1996
pubmed:articleTitle
Vasodilator effects of endothelin-converting enzyme inhibition and endothelin ETA receptor blockade in chronic heart failure patients treated with ACE inhibitors.
pubmed:affiliation
Medical Research Council Clinical Research Initiative in Heart Failure, University of Glasgow, Scotland, UK. m.love@biomed.gla.ac.uk
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Research Support, Non-U.S. Gov't